Imlygic

(herpesvirus 1, human)
1 ML talimogene laherparepvec 1000000 UNT/ML Injection [Imlygic]1 ML talimogene laherparepvec 100000000 UNT/ML Injection [Imlygic]
NO BLACK BOX WARNING

Dosage & administration

drug label

Imlygic prescribing information

Have more Imlygic questions?

Submit MSL Request
Learn More

Need to report an Imlygic issue?

ONLINE FORM
Report adverse event
Learn More

samples

Request Imlygic samples

NOT PROVIDED BY BRAND
View Online Sample Form
Learn More

prior authorization

Imlygic Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request
Coverage Authorization Appeals
Learn More

Benefits investigation

Benefit Verification
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Imlygic Financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Amgen Safety Net Foundation Patient Assistance Program
Learn More

patient education

Imlygic Patient education

Getting started on Imlygic

NOT PROVIDED BY BRAND
Instructions For Use: Melanoma

Patient toolkit

About Imlygic
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Imlygic
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.